Top Markets
Coin of the day
HeraMED Limited HeraMED Limited

HeraMED Limited

HMD
Rang in Aktien #28091
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Aktienkurs
$0.02468497
Marktkapitalisierung
$28.60M
Veränderung (1 Tag)
-5.41%
Veränderung (1 Jahr)
53.47%
Land
AU
Handel HeraMED Limited (HMD)

Kategorie

Dividendenrendite-Verlauf für HeraMED Limited (HMD)
Dividendenrendite (TTM) von HeraMED Limited (Aktienkürzel: HMD) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für HeraMED Limited (HMD) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber